Home › NDC Lookup › RxCUI directory › RxCUI 1090641

Triamcinolone acetonide 0.0005 MG/MG Topical Ointment — RxCUI 1090641

RxNorm drug concept · Semantic clinical drug
RxCUI 1090641 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1090641
Official nameTriamcinolone acetonide 0.0005 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astriamcinolone acetonide 0.05 % Topical Ointment
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)15,231 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
  • I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
  • That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
  • I have diabetes. Should I be worried about using triamcinolone?
📖 Read our full Triamcinolone guide →

🕸️ Concept Web — How Triamcinolone acetonide 0.0005 MG/MG Topical Oin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Triamcinolone acetonide 0.0005 MG/MG Topical Ointment RxCUI 1090641

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Triamcinolone 10759
    • Triamcinolone acetonide 10761
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trianex 1110803
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Triamcinolone Topical Ointment 374434
    • Triamcinolone acetonide Topical Ointment 2645397
    • Triamcinolone Topical Product 1158231
    • Triamcinolone acetonide Topical Product 2661113
    • Triamcinolone Topical Ointment [Trianex] 1110805
    • Triamcinolone acetonide Topical Ointment [Trianex] 2658854
    • Trianex Topical Product 1182127
    • Topical Ointment 316985
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Triamcinolone acetonide 0.0005 MG/MG 1090640
    • Triamcinolone acetonide 0.0005 MG/MG Topical Ointment [Trianex] 1110806
    • Triamcinolone acetonide 0.0005 MG/MG [Trianex] 1110804

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Triamcinolone acetonide 0.0005 MG/MG SCDC · 1090640
  • Triamcinolone Topical Ointment SCDF · 374434
  • Triamcinolone acetonide Topical Ointment SCDFP · 2645397
  • Triamcinolone Topical Product SCDG · 1158231
  • Triamcinolone acetonide Topical Product SCDGP · 2661113

Brand-Name Concepts

  • Triamcinolone acetonide 0.0005 MG/MG Topical Ointment [Trianex] SBD · 1110806
  • Triamcinolone acetonide 0.0005 MG/MG [Trianex] SBDC · 1110804
  • Triamcinolone Topical Ointment [Trianex] SBDF · 1110805
  • Triamcinolone acetonide Topical Ointment [Trianex] SBDFP · 2658854
  • Trianex Topical Product SBDG · 1182127
  • Trianex BN · 1110803

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 1090641 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
21922-0024-11 430 g in 1 JAR (21922-024-11) Triamcinolone Acetonide Encube Ethicals, Inc. 2019-12-02
24470-0922-15 430 g in 1 JAR (24470-922-15) TRIAMCINOLONE ACETONIDE Cintex Services, LLC 2020-11-10
33342-0334-13 430 g in 1 JAR (33342-334-13) Triamcinolone acetonide Macleods Pharmaceuticals Limited 2023-08-18
45802-0817-01 430 g in 1 JAR (45802-817-01) triamcinolone acetonide Padagis Israel Pharmaceuticals Ltd 2021-03-01
46287-0010-11 110 g in 1 JAR (46287-010-11) Triamcinolone Acetonide CMP Pharma, Inc. 2021-08-23
63629-8708-01 430 g in 1 JAR (63629-8708-1) triamcinolone acetonide Bryant Ranch Prepack 2022-02-09
64380-0901-90 430 g in 1 JAR (64380-901-90) Triamcinolone Acetonide Strides Pharma Science Limited 2020-06-05
72162-1429-02 430 g in 1 JAR (72162-1429-2) triamcinolone acetonide Bryant Ranch Prepack 2024-06-18
72603-0319-01 430 g in 1 JAR (72603-319-01) Triamcinolone Acetonide Northstar Rx LLC 2024-11-01
Observed labelers: Bryant Ranch Prepack (2) · Cintex Services, LLC (1) · CMP Pharma, Inc. (1) · Encube Ethicals, Inc. (1) · Macleods Pharmaceuticals Limited (1) · Northstar Rx LLC (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.1682
Range $0.1682–$0.1682 · middle 50% $0.1682–$0.1682 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.